Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CILP Antikörper (Internal Region)

CILP Reaktivität: Human, Ratte, Maus, Hund WB, EIA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN453982
  • Target Alle CILP Antikörper anzeigen
    CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
    Bindungsspezifität
    • 16
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 26
    • 18
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Ratte, Maus, Hund
    Wirt
    • 20
    • 4
    • 2
    • 2
    Ziege
    Klonalität
    • 25
    • 3
    Polyklonal
    Konjugat
    • 12
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CILP Antikörper ist unkonjugiert
    Applikation
    • 25
    • 14
    • 13
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Spezifität
    This antibody recognizes CILP.
    Kreuzreaktivität (Details)
    Species reactivity (expected):Human, Mouse and Canine (Dog).
    Species reactivity (tested):Rat.
    Aufreinigung
    Ammonium Sulphate Precipitation followed by antigen Affinity Chromatography using the immunizing peptide.
    Immunogen
    Peptide with sequence C-NYRRTDHEDPRVK, from the internal region of the protein sequence according to NP_003604.2.
    Top Product
    Discover our top product CILP Primärantikörper
  • Applikationshinweise
    Peptide ELISA: Antibody Detection Limit Dilution: 1/128000. Western Blot: 0.1-0.3 μg/mL. Approx 150 kDa band observed in rat spinal cord lysates(calculated MW of 130 kDa according to human NP_003604.2 and of 130 kDa according toRat NP_001101631.1).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    Tris saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Target
    CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
    Andere Bezeichnung
    CILP1 (CILP Produkte)
    Synonyme
    CILP-1 antikoerper, HsT18872 antikoerper, 9830114D16 antikoerper, C130036G17Rik antikoerper, NTPPH antikoerper, CILP antikoerper, im:7137994 antikoerper, cartilage intermediate layer protein antikoerper, cartilage intermediate layer protein, nucleotide pyrophosphohydrolase antikoerper, cartilage intermediate layer protein 1 antikoerper, CILP antikoerper, Cilp antikoerper, cilp antikoerper, LOC100336614 antikoerper
    Hintergrund
    CILP, Cartilage Intermediate Layer Protein, is specifically expressed in the articular cartilage intermediate layer (it cannot be found in the superficial nor in the deepest layers) and is involved in scaffolding. Overexpression of this protein may lead to impairment of chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage. Antibodies against CILP are detected in patients with early-stage knee osteoarthritis and defects in this gene may be a cause of susceptibility to lumbar disk disease.Synonyms: CILP-1, Cartilage intermediate layer protein 1, Cartilage intermediate-layer protein
    Gen-ID
    8483
    NCBI Accession
    NP_003604
    UniProt
    O75339
Sie sind hier:
Kundenservice